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ABSTRACT
Objectives. The aim of the present 
study was to correlate clinical and 
laboratory data with those obtained by 
ultrasound (US) evaluation of the hip 
in a cohort of patients with rheumatoid 
arthritis (RA).
Methods. Fifty-two RA patients attend-
ing the Rheumatology Departments 
involved in the present study were en-
rolled. Demographic (age, gender), 
clinical (body mass index, disease du-
ration, treatments, history or current 
hip pain, tenderness by internal or ex-
ternal hip rotation or palpation of the 
greater trochanteric region), laboratory 
(erythrosedimentation rate, C-reactive 
protein, rheumatoid factor and anti-
bodies anti-citrullinated peptides) and 
clinimetric data (disease activity score 
28 – DAS28, Health Assessment Ques-
tionnaire – HAQ, Lequesne index) were 
collected. All patients underwent an US 
examination of both hips according to 
international guidelines.
Results. A total of 100 hips were 
scanned in 52 patients with RA. Ap-
proximately half of the patients re-
ported a history of hip pain, one fourth 
complained of current pain, and the 
physical examination (internal and/or 
external rotation and palpation of the 
greater trochanteric region) evocated 
pain up to 19% and 22% of the patients, 
respectively. US examination found 
signs of hip joint abnormalities in 42% 
of the patients; US changes indicative 
of hip joint inflammation and damage 
were detected respectively in 24% and 
32% of the cases. No patient presented 
power Doppler signal in the hip joint. 
A significant correlation between US 
pathological findings at hip level was 
found with clinical data (current pain 
and evocated pain by internal or exter-
nal hip rotation). Furthermore, US car-
tilage lesion correlated with age of the 
patient, and US bone erosions with the 
disease duration. No correlation was 
found between the sonographic assess-
ment and laboratory data, DAS 28, and 
Lequesne index. 
Conclusions. US abnormalities at hip 
joint level obtained in the present study 
correlated with clinical findings, while 
no correlation was found with DAS28 
or laboratory data. Further investiga-
tions are encouraged to clarify the US 
additional value at hip level in patients 
with RA.
Introduction
Rheumatoid arthritis (RA) is a chronic, 
systemic autoimmune inflammatory 
disease which mainly affects the diar-
throdial joint and clinically manifests as 
joint pain, stiffness, and swelling (1).
The hip joint is frequently affected and 
its involvement can progressively lead 
to secondary osteoarthritis with a con-
sequent joint damage requiring total 
joint replacement in case of aggressive 
disease (2-5). RA represents the third 
most common cause for lower limb 
joint replacement in North America 
and Northern Europe (6). In spite of the 
impact of hip joint inflammation on the 
quality of life in RA patients (7), little 
is known about its involvement in RA, 
starting from its real prevalence.
Ultrasound (US) has been shown to be 
a suitable and sensitive imaging tech-
nique to assess joints, revealing both 
signs of inflammation (joint cavity 
widening, caused by effusion and/or 
synovial hypertrophy, and pathological 
perfusion, detectable using power Dop-
pler technique) and joint damage (car-
tilage lesions and bone abnormalities) 
(8-14). US may be particularly useful 
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in hip assessment overcoming the lim-
its of the clinical examination.
The aim of present study was to cor-
relate clinical and laboratory data with 
those obtained by US evaluation of the 
hip in patients with RA.
Patients and methods
Fifty-two RA patients attending the 
out-patient or in-patient clinics of five 
centres (Rheumatology Department of 
the Università Politecnica delle Marche, 
University of Pisa, University of Pavia, 
the Sapienza University of Rome, in Ita-
ly, and Antrim Hospital, in Northern Ire-
land, UK) were consecutively enrolled 
in this study. All patients fulfilled the 
1987 American College of Rheumatol-
ogy criteria or the 2010 American Col-
lege of Rheumatology/European League 
Against Rheumatism classification crite-
ria for rheumatoid arthritis (15, 16).
Clinical assessment
All patients underwent a complete 
clinical examination carried out by an 
expert rheumatologist and the outcome 
measures to evaluate the disease activi-
ty score (DAS28, disease activity score 
in 28 joints) and health assessment 
(HAQ, Health Assessment Question-
naire) were acquired (17-19).
Furthermore, for both hip joints the fol-
lowing data were recorded: previous or 
current hip pain, tenderness during ex-
ternal or internal rotation, and evocated 
by the palpation of the great trochanter 
region. Current therapy was recorded 
(use of DMARDs, biological agents, 
NSAIDs, and corticosteroids).
The Lequesne index, originally devel-
oped for assessing severity of hip os-
teoarthritis, was adopted as index to  
clinically evaluate hip disease (21).
C-reactive protein (CRP), erythrosedi-
mentation rate (ESR) and presence or 
absence of rheumatoid factor and anti-
bodies anti-citrullinated peptides were 
obtained as laboratory tests.
US scanning technique and image 
interpretation
US hip assessment was carried out ac-
cording to EULAR guidelines for mus-
culoskeletal US in rheumatology using 
a Logiq 9 machine (General Electrics 
Medical Systems, Milwaukee, WI) 
equipped with a 6–8 MHz multi-fre-
quency linear probe (22).
The patient was supine with the hip in 
neutral position (or with a slight exter-
nal rotation, as proposed by Koski et 
al.) for the anterior aspect assessment 
(22, 23). The lateral aspect was scanned 
with the patient lying on the opposite 
hip assuming an oblique lateral or 
true lateral position (according to the 
Musculoskeletal Ultrasound Technical 
Guidelines - Hip, from the European 
Society of Musculoskeletal Radiology) 
(24). Adopting this patient position, the 
following areas were examined: hip 
joint, and distal insertion of gluteus me-
dius and gluteus minimus tendon. 
The following US pathological findings 
were recorded (presence/absence): joint 
synovial effusion, synovial hypertrophy 
(with or without power Doppler signal), 
bone erosion, osteophytes, damage of 
the femoral head cartilage; enthesopa-
thy (for gluteus medius and gluteus 
minimus tendon). Furthermore, for 
each joint, the capsular height (distance 
between the ilio-femoral ligament and 
the femoral neck) was calculated in mil-
limeters. The hip joint cavity widening 
was considered if this distance was ≥7 
mm or the right-left comparison shown 
a value >1 mm (23). Synovial effusion 
and hypertrophy, bone erosion and en-
thesopathy were considered according 
to the preliminary definition provided 
by Outcome Measures in Rheumatoid 
Arthritis Clinical Trials (OMERACT) 
(25). Osteophytes and cartilage dam-
age were defined as previously (26, 27), 
respectively. Power Doppler setting pa-
rameters were adjusted according to the 
indications provided by Torp-Pedersen 
et al. (28). Each pathological US find-
ing was confirmed in almost two per-
pendicular scans.
Informed consent was obtained from 
all the patients and the study was car-
ried out after approval by the local eth-
ics committee according to the declara-
tion of Helsinki.
Statistical analysis
Descriptive results are reported as me-
dian ± standard deviation (SD). The 
relationship between different vari-
ables was analysed using Spearman’s 
rank correlation test. P-values less than 
0.05 were considered statistically sig-
nificant.
Results
A total of 100 hips were scanned in 52 
patients with RA. Four patients under-
went unilateral total hip replacement 
and data acquired at those four hips 
were not included in the overall results. 
The demographic and clinical data of the 
enrolled patients are reported in Table I.
Correlation between US findings and 
demographic, laboratory, and clinical 
data are shown in Table II.
Approximately half of our patients re-
ported a history of hip pain, one fourth 
(24%) complained of current pain, and 
the clinical examination (internal and/
or external rotation and palpation of the 
greater trochanteric region) evocated 
pain up to 19% and 22% of the patients, 
respectively.
Table I. Demographic, clinical, laboratory 
and US data.
A
Number of patients 52
Age in years (median±SD) 62 ± 15
Male/female (n) 13/39
Disease duration, months 116 ± 88 
   median±SD) 
ERS, mm/h (median±SD) 14 ± 18.6
CRP, mg/dl (median±SD) 0.36 ± 2.99
BMI, kg/m2 (median±SD) 22.9 ± 3
NSAIDs (n. %) 8.15
Steroids (n. %) 26.50
DMARDs (n. %) 28.54
Biological agent (n. %) 23.44
Rheumatoid factor (n. %) 32.62
Antibodies anti-citrullinated 27.52 
   peptides (n. %) 
DAS28 (median±SD) 3.1 ± 1.1
Lequesne index (median±SD) 2 ± 5
HAQ score (median±SD) 0.7 ± 0.8
B
Number of hips 100
History of hip pain  50
Current spontaneous hip pain 48
Evocated pain by internal and 38 
   external rotation of the hip  
Evocated pain by the palpation 44 
   of the great trochanter region 
US hip joint inflammation 27
US synovial effusion 24
US synovial hypertrophy 24
US hip joint damage 32
US bone erosions 10
US cartilage lesion 32
US osteophytes 18
US: ultrasound; SD: standard deviation; BMI: body 
mass index; ESR: erythrosedimentation rate; CRP: 
C-reactive protein; DAS28: Disease Activity Score 
28; HAQ: Health Assessment Questionnaire.
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US examination found signs of hip 
joint abnormalities in 42% of the pa-
tients; US changes indicative of hip 
joint inflammation and damage were 
detected respectively in 24% and 32% 
of the cases. A pathological measure-
ment of the capsular height was re-
corded in 42% of patients. No patient 
presented power Doppler signal in the 
hip joint. Figure 1 shows representative 
examples of US findings indicative of 
hip joint inflammation and damage.
A significant correlation was found be-
tween age and cartilage damage, and 
disease duration and the presence of 
bone erosions and osteophytes, respec-
tively, while age and disease duration 
have not resulted to correlate either 
with synovial effusion and/or hypertro-
phy or with the value of measurement 
of the joint distension in the anterior 
recess. Body mass index (BMI) pre-
sented a significant correlation only 
with the cartilage involvement.
Taking into account the laboratory tests, 
we did not find any correlation between 
either acute phase reactants (ESR and 
CRP) or rheumatoid factor and anti-
bodies anti-citrullinated peptides with 
any US finding of joint involvement. 
We found no significant correlations between clinimetric measurements 
Table II. p-value of correlations between US findings and demographic, clinical, and laboratory data.
 Capsular  Synovial Synovial Bone Cartilage Osteophytes 
 height effusion  hypertrophy  erosions  lesion  
Age (years)  0.17 0.90 0.80 0.47 0.02 0.21 
Disease duration (months) 0.95 0.91 0.45 0.02 0.06 0.04 
BMI (kg/m2)  0.73 0.78 0.89 0.06 0.01 0.57 
ESR (mm/h)  0.94 0.79 0.62 0.60 0.06 0.82 
CRP (mg/dl)  0.99 0.37 0.92 0.81 0.17 0.31 
Rheumatoid factor 0.17 0.46 0.17 0.89 0.70 0.63 
Antibodies anti-citrullinated peptides 0.14 0.30 0.67 0.60 0.69 0.79 
Lequesne index 0.20 0.13 0.21 0.19 0.30 0.80 
DAS 28  0.82 0.67 0.42 0.54 0.75 0.81 
HAQ  0.27 0.20 0.35 0.89 0.10 0.23 
                                           0.092   0.048 
     0.039 
 
 Capsular Synovial Synovial Bone Cartilage Osteophytes Minimus and/or
 height  effusion  hypertrophy  erosions  lesion   medius gluteus  
       tendinopathy
History of hip pain 0.046 0.15 0.09 0.21 0.04 0.005 0.89
Current spontaneous hip pain 0.010 0.31 0.007 0.28 0.64 0.07 0.34
Evocated pain by internal and 0.016 0.009 0.002 0.007 0.006 0.24 0.46 
   external rotation of the hip 
Evocated pain by the palpation 0.28 0.43 0.21 0.68 0.13 0.13 0.34
   of the great trochanter region  
BMI: body mass index; ESR: erythrosedimentation rate; CRP: C-reactive protein; DAS28: Disease Activity Score 28; HAQ: Health Assessment 
Questionnaire.
Fig. 1. Hip joint. Longitudinal anterior scan. A. Healthy subject. B-F. Images showing representative 
examples of US findings indicative of hip joint inflammation and damage. In B, synovial effusion (°), 
bone erosion (arrow), and cartilaginous lesion (arrowhead); in C, synovial effusion (°) and hypertro-
phy (*); in D, synovial hypertrophy, with an evident joint cavity widening (convexity of the capsular 
outline at femoral neck level); in E, synovial hypertrophy (*) with a minimal joint cavity widening 
(concavity of the capsular outline at femoral neck level) and capsular height less than 7 mm (dotted 
line); in F, synovial effusion (°) and hypertrophy (*), an osteophyte (dotted arrow) and cartilage dam-
age (arrowhead). a: acetabulum; f: femur.
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(DAS28 or Lequesne index), and US 
signs of hip involvement.
HAQ score did not correlate signifi-
cantly with any specific US pathologi-
cal finding, but a positive correlation 
was found with the presence of at least 
one US pathological finding.
As regards clinical findings, there was 
a significant correlation between the 
tenderness during internal and external 
rotation and all US findings indicative 
of hip joint disease, except capsular 
height and osteophytes.
Discussion
To the best of our knowledge, this is the 
first study in RA patients, aimed to in-
vestigate the correlation of clinical and 
laboratory data with US findings indic-
ative of abnormalities in the hip area, 
including both joint and peri-articular 
structures.
Even if in the recent ACR/EULAR clas-
sification criteria for RA, large joints 
have a lower weight than small joints 
in the score-based algorithm, their in-
volvement is not uncommon and is 
clinically relevant. A radiographic evi-
dence of disease has been reported in 
up to 90% for the shoulder, 60% for the 
elbow, 30% for the knee (2-6). At hip 
level, 20–50% of well-established RA 
subjects present radiographic signs of 
the disease, with relevant impact on the 
quality of life (3, 4).
We found that more than half of the 
patients recruited in the present study 
experienced past and/or current pain at 
hip level. It is interesting to note that 
tenderness was induced by the internal 
and/or external rotation only in 56% of 
patients with current spontaneous pain, 
suggesting that they may refer “hip 
joint pain” even when also extra-artic-
ular structures are involved (in half of 
the cases, tendinopathy of gluteus min-
imus and/or medius was found).
The US assessment revealed hip abnor-
malities in almost half of the patients, 
and osteochondral pathology resulted 
more common than synovial effusion/
hypertrophy (one fourth and one third, 
respectively). 
Measurement of the capsular height 
provided a higher number of inflamed 
hip joints with respect to the detection 
of synovial effusion and/or hypertrophy, 
suggesting a discrepancy between the 
quantitative assessment and the qualita-
tive one. In the absence of a gold stand-
ard it is impossible to establish if these 
data are related to the fact that the latter 
assessment underestimates or the former 
one overestimates the hip involvement. 
The difficulty in the qualitative detec-
tion of joint cavity widening when only 
a small amount of synovial hypertrophy 
with no concomitant joint effusion is 
present, may explain this discrepancy. 
This is supported by the fact that in 2 of 
the 3 cases with a pathological capsu-
lar height value less than 7 mm, arising 
from the right-left comparison higher 
than 1 mm, no fluid was found in the 
pathological side. Thus, it is important 
to underline the importance of a com-
parative assessment of hip joint.
The absence of power Doppler signal 
at synovial tissue level is in line with 
the results of other studies using US 
to assess the hip. The most likely ex-
planation is related to the depth of the 
joint, especially in overweight patients, 
which requires low frequency probes 
with a consequent reduction of power 
Doppler sensitivity (29, 30).
Cartilage damage was the most com-
mon US finding indicative of hip joint 
damage. Osteophytes were found in al-
most one fifth of cases and such a per-
centage is similar to that obtained in a 
recent paper conducted in patients with 
psoriatic arthritis (30).The relative low 
prevalence of US bone erosions can be 
explained by the limited acoustic win-
dow (30). 
The disease duration correlated posi-
tively with bone erosions and osteo-
phytes, but not with cartilage lesion. 
This may be interpreted as the result of 
the fact that in RA patients the cartilage 
involvement can occur in the earliest 
stage of the hip joint damage. More-
over, the positive correlation between 
the cartilage damage and the BMI sup-
ports the role of the mechanical factor.
In contrast with the positive correlation 
observed in other inflammatory arthri-
tis, no correlation between acute phase 
reactants and hip involvement was ob-
served in the RA patients of the present 
study. In a recent paper it has been 
shown that CRP values were higher in 
subjects affected by ankylosing spond-
ylitis presenting US abnormalities at 
hip joint level (31). The authors argued 
that a high CRP value can be consid-
ered an important laboratory parameter 
to perform an US examination of the 
hip even in asymptomatic patients with 
ankylosing spondylitis (31). According 
to our results, the decision to scan the 
hip in patients with RA should not de-
pend only on the laboratory findings.
No correlation was found between 
DAS28 and US signs of hip disease. 
This can be considered an expected re-
sult considering that the calculation of 
DAS28 does not include the hip among 
the count of tender and/or swollen joints. 
Nevertheless, these data, together with 
those about ESR and CRP, suggest a 
lack of correlation between hip involve-
ment and disease activity in RA.
Moreover, the Lequesne index was not 
correlated with sonographic abnormal-
ities at hip level. A possible explana-
tion can be the fact that this index was 
designed for hip osteoarthritis. In RA 
the final value may be influenced by 
the concomitant involvement of other 
anatomic sites of the lower limbs, such 
as knee, ankle or foot.
If considered separately, each US find-
ing did not reach a significant correlation 
with the HAQ score. We found a signifi-
cant correlation between HAQ score and 
the presence of US evidence of hip joint 
damage, suggesting an important role of 
this in the global health of RA.
We found a significant correlation be-
tween the tenderness caused by internal 
and external rotation and all US find-
ings indicative of hip joint involvement 
(with the exception of the presence of 
osteophytes). On the other hand, a his-
tory of hip pain and a spontaneous cur-
rent hip pain correlated with synovial 
hypertrophy, and cartilage damage and 
osteophytes, respectively.
These data underline that an accurate 
physical examination is a fundamental 
step for the physician to reveal hip in-
volvement in RA patients. Nevertheless, 
it does not give univocal information in-
dicative for the presence of active joint 
inflammation or early joint damage. 
For extra-articular structures, it could be 
interesting to note the lack of correlation 
between tenderness by palpation of the 
greater trochanteric region and the pres-
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ence of gluteus minimum and/or medius 
tendinopathy. However, the presence of 
tendinopathy in the greater trochanteric 
region is commonly described by the 
patient as a “hip pain”, representing a 
potential confusing factor.
Taking all these data together, we may 
argue that in an elderly patient with 
long-standing RA we can expect to find 
US osteochondral abnormalities, while 
a current spontaneous pain, especially 
when enhanced by mobilisation of the 
hip, suggests the presence of US evi-
dence of hip joint inflammation, such 
as synovial fluid and/or pannus.
The results of the present study should 
be interpreted in the light of the follow-
ing limitations. Firstly, given the small 
cohort and the consequent small sample 
size effect, it must be considered as a 
preliminary study. The number of en-
rolled patients did not allow us to cal-
culate data of prevalence. Furthermore, 
the present study is a cross-sectional 
study and does not provide longitudinal 
information. A larger cohort and a lon-
gitudinal evaluation are required to se-
lect sub-groups of patients and to assess 
the effect of different parameters on the 
patient outcome. Finally, the lack of a 
“gold standard” technique in assessing 
the hip inflammatory changes did not 
allow us to extrapolate information on 
sensitivity and specificity of clinical 
and US examinations, and a compari-
son between these two assessments.
In conclusion, hip pain is common in 
patients with RA, and both clinical 
and US assessments were positive in a 
high number of patients. Furthermore, 
we found a strong correlation between 
some clinical features and US findings 
indicative of hip joint involvement in 
RA. Nevertheless, an accurate collec-
tion of clinical history and physical 
examination can only lead to the sus-
picion of hip pathology which requires 
imaging findings to be confirmed. Fi-
nally, laboratory data may not help the 
physician to identify RA patients with 
a high suspicion of hip involvement. 
The results of the present study sug-
gest the need to integrate the clinical 
and laboratory-based assessment of the 
hip in RA with the US examination to 
confirm the suspicion or to reveal sub-
clinical hip involvement. 
Further studies are needed to evaluate 
if the additional data obtained by US 
can play a role in predicting the pa-
tient’s outcome and in the treatment 
decision making.
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